GCEMS Protocol:

 

• Reative Airway Disease

 

Indications:

 

• Bronchial asthma
• Reversible bronchospasm associated with chronic obstructive pulmonary disease

 

Contraindications:

 

• Patients with known hypersensitivity to the medication
• A-Fib RVR

 

Side Effects:

 

• Tachyarrhythmias

 

Adult:

 

• 0.25 mg SQ may be repeated once after 20 minutes

 

Peds:

 

• 0.01 mg/kg, not to exceed 0.25 mg may repeat once after 20 minutes